You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-C5aR

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)

Recruiting
  • Bullous Pemphigoid
  • Avdoralimab (IPH5401)
  • Control
  • Nice, Alpes-Maritimes, France
  • +3 more
Feb 18, 2022

Advanced Solid Tumors Trial in France, United States (IPH5401 and Durvalumab)

Terminated
  • Advanced Solid Tumors
  • IPH5401 and Durvalumab
  • Louisville, Kentucky
  • +11 more
Jan 12, 2022

COVID Trial in Marseille (avdoralimab, Placebo)

Completed
  • COVID
  • avdoralimab
  • Placebo
  • Marseille, France
    Assistance Publique Hôpitaux de Marseille
May 26, 2021

SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor

Completed
  • SARS-CoV-2 (COVID-19) Infection
  • Advanced or Metastatic Hematological or Solid Tumor
  • Autophagy inhibitor (GNS651)
  • +3 more
  • Lyon, Rhône, France
  • +11 more
Sep 29, 2022

Obesity, Morbid, Bariatric Surgery, Adolescent Trial in Aurora (Phentermine, Immediate Release Topiramate, Placebo for

Completed
  • Obesity, Morbid
  • +4 more
  • Aurora, Colorado
    Children's Hospital Colorado
Mar 7, 2022

Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • Anti-C5 antibody treatment
  • Paris, France
    AP-HP Hôpital Saint Louis
Apr 24, 2023

Atypical Hemolytic Uremic Syndrome Trial (Iptacopan)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • (no location specified)
Jun 29, 2023

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Nov 18, 2022

    Macular Degeneration Trial (Zimura, Avastin, Lucentis)

    Completed
    • Macular Degeneration
    • (no location specified)
    Oct 4, 2022

    Advanced Solid Tumor Trial in Shanghai (TJ210001 Injection)

    Recruiting
    • Advanced Solid Tumor
    • TJ210001 Injection
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jun 24, 2022

    Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

    Not yet recruiting
    • Metastatic Colorectal Carcinoma
    • +3 more
    • Bevacizumab
    • +11 more
    • (no location specified)
    May 9, 2023

    Cat Bite, Hand Injuries, Arm Injury Trial (drug, other, procedure)

    Not yet recruiting
    • Cat Bite
    • +4 more
    • (no location specified)
    Apr 26, 2023

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

    Active, not recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 25, 2022

    Prostate Cancer Trial in Canada (Abiraterone acetate with prednisone, Leuprolide, Cabazitaxel with peg-filgrastim)

    Completed
    • Prostate Cancer
    • Abiraterone acetate with prednisone
    • +2 more
    • Vancouver, British Columbia, Canada
    • +4 more
    Apr 13, 2022

    Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +15 more
    • Bellevue, Nebraska
    • +3 more
    Nov 30, 2022

    Solid Tumors Trial in Worldwide (RO7296682, Atezolizumab)

    Recruiting
    • Solid Tumors
    • Duarte, California
    • +12 more
    Jan 31, 2023

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (LNP023, Eculizumab, Ravulizumab)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Duarte, California
    • +39 more
    Jan 13, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • Boston, Massachusetts
    • +5 more
    Jan 7, 2023

    Advanced Solid Tumors Trial in Canada, Singapore, United States (BAY3375968, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumors
    • Chicago, Illinois
    • +4 more
    Sep 9, 2022

    NSCLC, Tumors Trial in Canada, Poland, Romania (Debio 1143, Avelumab)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Neoplasms
    • Edmonton, Alberta, Canada
    • +8 more
    May 30, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +7 more
    • Aurora, Colorado
    • +7 more
    Nov 29, 2022

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

    Recruiting
    • Solid Tumor
    • +11 more
    • TRK-950
    • +14 more
    • Scottsdale, Arizona
    • +13 more
    Oct 2, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 20, 2023